Alignment Healthcare (ALHC) Is Growing ~46% While Medicare Advantage Peers Struggle

Alignment Healthcare rose about 10% on June 9 into a healthcare conference — a positioning move more than a hard catalyst. But the reason it is a high-conviction name for some investors is real: it is growing fast while the rest of Medicare Advantage struggles with costs.

Why it moved

Let me be straight: the June 9 move is positioning into a Goldman Sachs healthcare conference, not a fundamental event. The bull case underneath is what matters — Alignment grew FY2025 revenue about 46% and has 100% of members in 4-Star-or-better Medicare Advantage plans for 2026, a quality bar that drives reimbursement and retention while larger insurers fight margin pressure. In a sector under cost stress, a fast-growing, high-quality plan stands out.

What it means for you

Alignment is a high-growth, still-scaling MA insurer — the upside is share gains and improving economics as it grows into its star ratings; the risk is the perennial managed-care wildcard of medical-cost trends and a small-cap that swings on sentiment and short interest.

Bottom line: I find the growth-plus-quality combination genuinely interesting, but a 10% move into a conference is sentiment — I would judge ALHC on its medical-cost trend and membership growth, not on a conference-day pop.